Trial
NCT00840827
Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Myelodysplastic Syndromes
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Weill Medical College of Cornell University
Collaborators
Celgene
Condition
Myelodysplastic Syndrome
Intervention
lenalidomide
Why stopped
Lack of efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-19